Search for a command to run...
No change in shareholding patterns for Promoters, Institutions, and Public in Transgene Biotek Ltd., indicating a lack of interest or confidence.
The sector shows no movement either, suggesting a stagnant market environment in the Hospital and Healthcare Services sector.
Comparatively, SURAKSHA stands out with significant institutional buying, whereas other stocks like FORTIS and AGARWALEYE face substantial selling, highlighting overall sector disparity.
| Category | Trend | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter Holdings | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | 23.64% | |
2Public Holdings | 76.36% | 76.36% | 76.36% | 76.36% | 76.36% | 76.36% | 76.36% | 76.36% | |
3Foreign Investors | - | - | - | - | - | - | - | - | |
4Domestic Investors | - | - | - | - | - | - | - | - |